GGrantIndex
Sort

23,748 grants matching melanoma

Increasing the Potency of CD-34-DC Vaccines

$111,981
Jacques F Banchereau · Baylor Research Institute · P01 · FY2006 · CA

Administrative Core

$111,899
Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA

Population-Based Approach to Skin Cancer Epidemiology

$111,854
Abrar A Qureshi · Brigham And Women'S Hospital · K07 · FY2009 · CA

CANCER AND LEUKEMIA GROUP B

$111,810
University Of Maryland Baltimore · U10 · FY2000 · CA

ROLES OF NITRIC OXIDE AND OXYGEN IN OCULAR MELANOMA

$111,750
Wayne State University · R29 · FY2002 · EY

Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer

$111,730
Haydn Kissick · Emory University · K99 · FY2017 · CA

Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer

$111,730
Haydn Kissick · Emory University · K99 · FY2016 · CA

Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity

$111,690
Stefani Spranger · University Of Chicago · K99 · FY2016 · CA

CUTANEOUS ONCOLOGY

$111,617
University Of Texas Md Anderson Can Ctr · K24 · FY2004 · CA

FN FAK SIGNALING AXIS AND TUMORIGENESIS

$111,511
University Of California San Francisco · K01 · FY2001 · CA

Tissue and Research Pathology Services

$111,502
Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA

UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP

$111,482
University Of California Los Angeles · U10 · FY2000 · CA

Administrative Core

$111,474
James R. Heath · California Institute Of Technology · U54 · FY2011 · CA

Core 1: Administrative Core

$111,372
Marcus W Bosenberg · Yale University · P50 · FY2021 · CA

Core 1: Administrative Core

$111,359
Marcus W Bosenberg · Yale University · P50 · FY2019 · CA

A Pb-212 Generator Using Resistant Substrate and Rn Cold Trapping

$111,339
Gary John Ehrhardt · Alphamed, Inc · R41 · FY2009 · CA

Processing Ac-227 sources for lead-212 and radium-223 required by cancer research

$111,300
Chuck Z Soderquist · Alphamed, Inc · R41 · FY2007 · CA

Biologic therapy of Melanoma and Renal Cell Cancer

$111,192
Beth Israel Deaconess Medical Center · K24 · FY2002 · CA

SUN SAFETY--SKIN CANCER EDUCATION FOR FAMILY CHILD CARE

$111,112
Healthmark Multimedia, Llc · R43 · FY2000 · CA

Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics

$111,106
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

05 Cancer Chemoprevention Program

$111,104
Craig A Elmets · University Of Alabama At Birmingham · P30 · FY2017 · CA

Targeting Tumor Hypoxia with Radiohalogenated Inhibitors of Carbonic Anhydrase IX

$111,095
John Louis Joyal · Molecular Insight Pharmaceuticals, Inc. · R21 · FY2010 · CA

Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome

$111,083
Ronglai Shen · University Of New Mexico Health Scis Ctr · P01 · FY2019 · CA

The B7x pathway in the tumor microenvironment

$111,039
Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2015 · CA

ENDOGENOUS INHIBITORS OF ADAMS/MDC PROTEINASES

$111,000
University Of Virginia Charlottesville · R21 · FY2000 · GM